{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T11:16:40Z","timestamp":1762341400194,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.brachy.2019.12.001","type":"journal-article","created":{"date-parts":[[2020,1,18]],"date-time":"2020-01-18T23:31:12Z","timestamp":1579390272000},"page":"216-221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["A dosimetric evaluation of a single urethral constraint for high-dose-rate prostate brachytherapy"],"prefix":"10.1016","volume":"19","author":[{"given":"Diana J.","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiffany","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"DeMarco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard M.","family":"Sandler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell","family":"Kamrava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2019.12.001_bib1","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ijrobp.2008.05.003","article-title":"An eight-year experience of HDR brachytherapy boost for localized prostate cancer: biopsy and PSA outcome","volume":"73","author":"Bachand","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.12.001_bib2","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.ijrobp.2003.08.003","article-title":"Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer","volume":"58","author":"Galalae","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.12.001_bib3","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.brachy.2005.03.005","article-title":"Combined modality treatment with high-dose-rate brachytherapy boost for locally advanced prostate cancer","volume":"4","author":"Hsu","year":"2005","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2019.12.001_bib4","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ijrobp.2009.01.059","article-title":"Phase II trial of radiation dose escalation with conformal external beam radiotherapy and high-dose-rate brachytherapy combined with long-term androgen suppression in unfavorable prostate cancer: feasibility report","volume":"76","author":"Valero","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.12.001_bib5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ijrobp.2012.03.035","article-title":"High-dose-rate prostate brachytherapy consistently results in high quality dosimetry","volume":"85","author":"White","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.12.001_bib6","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1200\/JCO.2005.06.154","article-title":"Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate","volume":"23","author":"Sathya","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2019.12.001_bib7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.brachy.2009.04.007","article-title":"High-dose-rate brachytherapy in combination with conformal external beam radiotherapy in the treatment of prostate cancer","volume":"9","author":"Zwahlen","year":"2010","journal-title":"Brachytherapy"},{"year":"2019","series-title":"Clinical Practice Guidelines in Oncology. Prostate Cancer","key":"10.1016\/j.brachy.2019.12.001_bib8"},{"key":"10.1016\/j.brachy.2019.12.001_bib9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.brachy.2011.09.008","article-title":"American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy","volume":"11","author":"Yamada","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2019.12.001_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.prro.2013.02.011","article-title":"Dosimetric analysis of radiation therapy oncology group 0321: the importance of urethral dose","volume":"4","author":"Hsu","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.brachy.2019.12.001_bib11","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ijrobp.2017.01.008","article-title":"ASCENDE-RT: an analysis of treatment-related morbidity for a randomized trial comparing a low-dose-rate brachytherapy boost with a dose-escalated external beam boost for high- and intermediate-risk prostate cancer","volume":"98","author":"Rodda","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.12.001_bib12","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.brachy.2011.07.009","article-title":"Urethra low-dose tunnels: validation of and class solution for generating urethra-sparing dose plans using inverse planning simulated annealing for prostate high-dose-rate brachytherapy","volume":"11","author":"Cunha","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2019.12.001_bib13","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ijrobp.2004.11.041","volume":"63","author":"Akimoto","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.12.001_bib14","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ijrobp.2005.02.015","volume":"63","author":"Akimoto","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.12.001_bib15","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.ijrobp.2005.10.005","volume":"64","author":"Akimoto","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.12.001_bib16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijrobp.2008.11.006","volume":"75","author":"Ishiyama","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.12.001_bib17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.clon.2017.01.042","article-title":"Long-term toxicity and health-related quality of life after single-fraction high dose rate brachytherapy boost and hypofractionated external beam radiotherapy for intermediate-risk prostate cancer","volume":"29","author":"Shahid","year":"2017","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.brachy.2019.12.001_bib18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/jjco\/hyu173","article-title":"Correlation between the changes in the EPIC QOL scores and the dose-volume histogram parameters in high-dose-rate brachytherapy combined with hypofractionated external beam radiation therapy for prostate cancer","volume":"45","author":"Hashimoto","year":"2015","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.brachy.2019.12.001_bib19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.brachy.2008.09.004","article-title":"Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy","volume":"8","author":"Ghadjar","year":"2009","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2019.12.001_bib20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.radonc.2008.12.007","article-title":"Association of urethral toxicity with dose exposure in combined high-dose-rate brachytherapy and intensity-modulated radiation therapy in intermediate- and high-risk prostate cancer","volume":"91","author":"Ghadjar","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2019.12.001_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.radonc.2005.10.003","article-title":"Dose-volume impact in high-dose-rate Iridium-192 brachytherapy as a boost to external beam radiotherapy for localized prostate cancer--a phase II study","volume":"78","author":"Pinkawa","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2019.12.001_bib22","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.brachy.2015.06.004","article-title":"Patient- and treatment-specific predictors of genitourinary function after high-dose-rate monotherapy for favorable prostate cancer","volume":"14","author":"Raleigh","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2019.12.001_bib23","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.ijrobp.2007.07.2354","article-title":"Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: preliminary results of a multicenter prospective study","volume":"70","author":"Fiorino","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.12.001_bib24","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.brachy.2019.05.009","article-title":"A surrogate urethra for real-time planning of high-dose-rate prostate brachytherapy","volume":"18","author":"Halperin","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2019.12.001_bib25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.radonc.2013.05.002","article-title":"GEC\/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: an update","volume":"107","author":"Hoskin","year":"2013","journal-title":"Radiother Oncol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472119306506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472119306506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:15:10Z","timestamp":1761531310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472119306506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1538472119306506"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2019.12.001","relation":{},"ISSN":["1538-4721"],"issn-type":[{"type":"print","value":"1538-4721"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A dosimetric evaluation of a single urethral constraint for high-dose-rate prostate brachytherapy","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2019.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Brachytherapy Society.","name":"copyright","label":"Copyright"}]}}